EARNEST Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
EARNEST Partners's IDXX Position: Q4 2023 in Review
EARNEST Partners sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 47 shares — an estimated $20.6K sold.
EARNEST Partners first reported a position in IDXX in Q4 2016 and held it in 25 quarters. The position peaked at $31K in Q4 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.
- EARNEST Partners reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
- EARNEST Partners sold 47 Idexx Laboratories shares in Q4 2023, an estimated $20.6K.
- EARNEST Partners first reported a position in Idexx Laboratories in Q4 2016 and held it in 25 quarters.
- EARNEST Partners's Idexx Laboratories position peaked at $31K in Q4 2021.
- 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.
Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.